GB8610147D0 - Vasculoprotecting pharmaceutical compositions - Google Patents
Vasculoprotecting pharmaceutical compositionsInfo
- Publication number
- GB8610147D0 GB8610147D0 GB868610147A GB8610147A GB8610147D0 GB 8610147 D0 GB8610147 D0 GB 8610147D0 GB 868610147 A GB868610147 A GB 868610147A GB 8610147 A GB8610147 A GB 8610147A GB 8610147 D0 GB8610147 D0 GB 8610147D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- vasculoprotecting
- pharmaceutical compositions
- pharmaceutical
- compositions
- vasculoprotecting pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/15—Suppositories
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1826/85A CH662505A5 (it) | 1985-04-30 | 1985-04-30 | Composizioni farmaceutiche ad azione protettiva vascolare. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB8610147D0 true GB8610147D0 (en) | 1986-05-29 |
Family
ID=4219499
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB868610147A Pending GB8610147D0 (en) | 1985-04-30 | 1986-04-25 | Vasculoprotecting pharmaceutical compositions |
| GB8610588A Expired GB2174904B (en) | 1985-04-30 | 1986-04-30 | Vasculoprotecting pharmaceutical compositions |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8610588A Expired GB2174904B (en) | 1985-04-30 | 1986-04-30 | Vasculoprotecting pharmaceutical compositions |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4707360A (https=) |
| JP (1) | JPS61280424A (https=) |
| KR (1) | KR860007927A (https=) |
| AT (1) | AT393793B (https=) |
| BE (1) | BE904696A (https=) |
| CH (1) | CH662505A5 (https=) |
| DE (1) | DE3614278A1 (https=) |
| FR (1) | FR2587212B1 (https=) |
| GB (2) | GB8610147D0 (https=) |
| NL (1) | NL8601105A (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0383171A3 (en) * | 1989-02-11 | 1991-07-24 | Hoechst Aktiengesellschaft | 2,3,23-trihydroxy-urs-12-ene derivatives for treating cognitive disorders |
| FR2645442A1 (fr) * | 1989-04-07 | 1990-10-12 | Gueyne Jean | Produit therapeutique a base de compose organique du silicium et de polyamine polycarboxylee, particulierement utile pour le traitement de l'atherome |
| GB8926715D0 (en) * | 1989-11-28 | 1990-01-17 | Haessle Ab | Improvements relating to the administration of pharmaceutical agents |
| IE911403A1 (en) * | 1990-04-26 | 1991-11-06 | Cytrx Corp | Compositions and method for topical treatment of damaged or¹diseased tissue |
| FR2661830B1 (fr) * | 1990-05-11 | 1992-09-04 | Corbiere Jerome | Nouvelle compositions pharmaceutiques a base de flavonoside. |
| US5234914A (en) * | 1991-06-11 | 1993-08-10 | Patent Biopharmaceutics, Inc. | Methods of treating hemorrhoids and anorecial disease |
| US5399584A (en) * | 1992-05-05 | 1995-03-21 | The Procter & Gamble Company | Use of flavone derivatives for gastroprotection |
| FR2692145B1 (fr) * | 1992-06-10 | 1995-05-05 | Bellon Labor Sa Roger | Nouvelle composition à usage topique contenant de la diosmine. |
| IT1265312B1 (it) * | 1993-12-21 | 1996-10-31 | Indena Spa | Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di |
| GB9425487D0 (en) * | 1994-12-16 | 1995-02-15 | Res Inst | Osteoarthritis treatment |
| US5683678A (en) * | 1995-03-09 | 1997-11-04 | The Procter & Gamble Company | Oral compositions |
| JP2001504514A (ja) * | 1996-11-27 | 2001-04-03 | ドング クック ファーマシューティカル シーオー.,エルティーディー. | アシアト酸誘導体を有効成分とする痴呆及び認識障害治療剤 |
| KR100530278B1 (ko) | 1997-02-28 | 2006-04-06 | 동국제약 주식회사 | 아시아트산 유도체를 유효성분으로 하는 간 보호 및치료제 |
| US6077534A (en) * | 1997-09-02 | 2000-06-20 | Klinge Pharma Gmbh | Production of pharmaceutical formulations for treatment of edema and venous disorders |
| US6159494A (en) * | 1997-12-03 | 2000-12-12 | Widgerow; Alan D | Treatment of post operative scars with a tape containing a gel from Bulbine frutescens |
| US6423742B1 (en) | 1999-09-02 | 2002-07-23 | Drake Larson | Compositions for reducing vascular plaque formation and methods of using same |
| US6562864B1 (en) | 1999-09-02 | 2003-05-13 | Drake Larson | Catechin multimers as therapeutic drug delivery agents |
| ATE287723T1 (de) * | 1999-09-10 | 2005-02-15 | Ceteris Holding B V Amsterdam | Ein antioxydierungsmittel auf basis von pflanzenextrakten zur behandlung von kreislaufs- und chronischen degenerativen problemen und von bluthochdruck |
| DE60019314T2 (de) * | 1999-09-10 | 2006-04-27 | Ceteris Holding B.V.-Amsterdam (Olanda) - Succursale Di Lugano | Ein antioxyrierungsmittel auf basis von pflanzenextrakten zur behandlung von kreislaufs- und fettsuchtproblemen |
| WO2002069992A1 (en) * | 2001-03-02 | 2002-09-12 | Biopharmacopae Design International Inc. | Plant extracts and compositions comprising extracellular protease inhibitors |
| JP2002293736A (ja) * | 2001-03-30 | 2002-10-09 | Sunstar Inc | メーラード反応阻害剤およびそれを含有する組成物 |
| DE20109044U1 (de) * | 2001-05-30 | 2001-08-09 | Weber & Weber GmbH & Co. KG, 82266 Inning | Pharmazeutische Zubereitung |
| US6981883B2 (en) * | 2001-11-14 | 2006-01-03 | Fci Americas Technology, Inc. | Impedance control in electrical connectors |
| WO2004064543A1 (ja) * | 2003-01-17 | 2004-08-05 | Taiyo Kagaku Co., Ltd. | コエンザイムq10含有組成物 |
| US20070122492A1 (en) * | 2004-11-18 | 2007-05-31 | Stephen Behr | Plant extracts and dermatological uses thereof |
| US20070010459A1 (en) * | 2005-01-14 | 2007-01-11 | Ying Liu | Application of asiatic acid and its derivatives to treat pulmonary fibrosis |
| US8071139B2 (en) * | 2008-09-04 | 2011-12-06 | Alan David Widgerow | Treatment of damaged skin |
| US8591961B2 (en) | 2008-09-04 | 2013-11-26 | Allergan, Inc. | Aesthetic treatment of scars and aging skin |
| EP2353596A1 (en) * | 2010-02-02 | 2011-08-10 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1157269B (it) * | 1982-03-19 | 1987-02-11 | Seuref Ag | Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica |
| CH655005A5 (it) * | 1983-02-16 | 1986-03-27 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare. |
| CH670763A5 (https=) * | 1985-08-02 | 1989-07-14 | Seuref Ag |
-
1985
- 1985-04-30 CH CH1826/85A patent/CH662505A5/it not_active IP Right Cessation
-
1986
- 1986-04-25 GB GB868610147A patent/GB8610147D0/en active Pending
- 1986-04-26 DE DE19863614278 patent/DE3614278A1/de active Granted
- 1986-04-28 JP JP61099302A patent/JPS61280424A/ja active Granted
- 1986-04-29 US US06/857,152 patent/US4707360A/en not_active Expired - Lifetime
- 1986-04-29 BE BE2/60974A patent/BE904696A/nl unknown
- 1986-04-29 KR KR1019860003298A patent/KR860007927A/ko not_active Ceased
- 1986-04-29 AT AT0115186A patent/AT393793B/de not_active IP Right Cessation
- 1986-04-29 NL NL8601105A patent/NL8601105A/nl not_active Application Discontinuation
- 1986-04-30 GB GB8610588A patent/GB2174904B/en not_active Expired
- 1986-04-30 FR FR868606270A patent/FR2587212B1/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| GB2174904A (en) | 1986-11-19 |
| CH662505A5 (it) | 1987-10-15 |
| BE904696A (nl) | 1986-08-18 |
| NL8601105A (nl) | 1986-11-17 |
| DE3614278A1 (de) | 1986-10-30 |
| JPS61280424A (ja) | 1986-12-11 |
| KR860007927A (ko) | 1986-11-10 |
| FR2587212A1 (fr) | 1987-03-20 |
| AT393793B (de) | 1991-12-10 |
| ATA115186A (de) | 1991-06-15 |
| JPH0344048B2 (https=) | 1991-07-04 |
| GB8610588D0 (en) | 1986-06-04 |
| GB2174904B (en) | 1989-07-05 |
| FR2587212B1 (fr) | 1992-05-29 |
| US4707360A (en) | 1987-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB8626808D0 (en) | Pharmaceutical compositions | |
| GB8524001D0 (en) | Pharmaceutical composition | |
| GB2174904B (en) | Vasculoprotecting pharmaceutical compositions | |
| GB8602787D0 (en) | Pharmaceutical composition | |
| GB8602788D0 (en) | Pharmaceutical composition | |
| GB8621577D0 (en) | Pharmaceutical compositions | |
| GB8530796D0 (en) | Pharmaceutical composition | |
| GB2171600B (en) | Pharmaceutical compositions | |
| GB8602625D0 (en) | Pharmaceutical compositions | |
| GB8618820D0 (en) | Pharmaceutical compositions | |
| EP0197752A3 (en) | Pharmaceutical compositions | |
| GB8618249D0 (en) | Pharmaceutical compositions | |
| GB8515170D0 (en) | Pharmaceutical compositions | |
| GB8602602D0 (en) | Pharmaceutical compositions | |
| GB8607848D0 (en) | Pharmaceutical compositions | |
| GB8618590D0 (en) | Pharmaceutical compositions | |
| GB2182561B (en) | Pharmaceutical compositions | |
| GB8523531D0 (en) | Pharmaceutical compositions | |
| GB8610970D0 (en) | Pharmaceutical compositions | |
| GB8618589D0 (en) | Pharmaceutical compositions | |
| GB8522327D0 (en) | Pharmaceutical compositions | |
| GB8602601D0 (en) | Pharmaceutical compositions | |
| GB8608309D0 (en) | Pharmaceutical compositions | |
| GB8608310D0 (en) | Pharmaceutical compositions | |
| GB8502887D0 (en) | Pharmaceutical compositions |